Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 305-314

  Konishi, Noboru ^a   Hiasa, Yoshio ^a   Nakamura, Mitsutoshi ^a   Kitahori, Yoshiteru ^a   Matsubara, Kenichi ^b   Nagai, Hisaki ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENDONUCLEASE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA; CELL DIVISION; DNA, NEOPLASM; HUMANS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROSTATIC NEOPLASMS; RESTRICTION MAPPING;

EID: 0031021558     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Giovannucci E: Epidemiologic characteristics of prostate cancer. Cancer 1995, 75:1766-1777
2. Konishi N, Enomoto T, Buzard G, Ohshima M, Ward JM, Rice JM: K-ras activation and ras p21 expression in latent prostatic carcinoma. in Japanese men. Cancer 1992, 69:2293-2299
3. Miller GJ, Cygan JM: Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume, and capsule penetration. J Urol 1994, 152:1709-1713
4. Konishi N, Hiasa Y, Matsuda H, Tao M, Tsuzuki T, Hayashi I, Kitahori Y, Shiraishi T, Yatani R, Shimazaki J, Un J-C: Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol 1995, 147:1112-1122
5. Sakr WA, Macoska JA, Benson P, Grignon DJ, Wolman SR, Pontes JE, Crissman JD: Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 1994, 54:3272-3277
6. Joos S, Bergerheim US, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P: Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Gene Chromosomes & Cancer 1995, 14:267-276
7. Hirotsune S, Hatada I, Komatsubara H, Nagai H, Kuma K, Kobayakawa K, Kawara T, Nakagawara A, Fujii K, Mukai T, Hayashizaki Y: New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning method. Cancer Res 1992, 52:3642-3647
8. Nagai H, Hirotsune S, Komatsubara H, Hatada I, Mukai T, Hayashizaki Y, Matsubara K: Genomic analysis of human hepatocellular carcinomas using restriction landmark genomic scanning. Cancer Detect Prev 1993, 17:399-404
9. Nagai H, Ponglikitmongkol M, Mita E, Ohmachi Y, Yoshikawa H, Saeki R, Yumoto Y, Nakanishi T, Matsubara K: Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 1994, 54:1545-1550
10. Gleason DF: Classification of prostatic carcinomas. Cancer Chemother Rep 1966, 50:125-128
11. Blin N, Srafford DW: A general method for isolation of high molecular weight DNA from eukaryotes, Nucleic Acids Res 1976, 3:2303-2308
12. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T: A genomic scanning method for higher organisms using restriction sites as landmark. Proc Natl Acad Sci USA 1991, 88:9523-9527
13. Garrels JI: The QUEST system for quantitative analysis of two-dimensional gels. J Biol Chem 1989, 264:5269-5282
14. Yoshikawa H, De La Monte S, Nagai H, Wands JR, Matsubara K, Fujiyama A: Chromosomal assignment of human genomic Notl restriction fragments in a two-dimensional electrophoresis profile. Genomics 1996, 31:28-35
15. Peehl DM: Oncogenes in prostate cancer: an update. Cancer 1993, 71:1159-1164
16. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM: Molecular genetics and chromosomal alterations in prostate cancer. Cancer 1995, 75:2004-2012
17. Konishi N, Hiasa Y, Tsuzuki T, Tao M, Enomoto T, Miller GJ: Comparison of ras activation in prostate carcinoma in Japanese and American men. Prostate 1997 (in press)
18. Carter BS, Epstein JI, Isaacs WB: ras gene mutations in human prostate cancer. Cancer Res 1990, 50:6830-6832
19. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW: Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res 1991, 51:1632-1637
20. Moul JW, Friedrichs PA, Lance RS, Theune SM, Chang EH: Infrequent ras oncogene mutation in human prostate cancer. Prostate 1992, 20:327-328
21. Nag A, Smith RG: Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP. Prostate 1989, 15:115-122
22. Fukumoto M, Shevrin DH, Roninson IB: Analysis of gene amplification in human tumor cell lines. Proc Natl Acad Sci USA 1988, 85:6846-6850
23. Sitaras NM, Sariban E, Bravo M, Pantazis P, Antoniades HN: Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. Cancer Res 1988, 48:1930-1935
24. Roninson IB: Detection and mapping of homologous, repeated, and amplified DMA sequences by DNA renaturation in agarose gel. Nucleic Acids Res 1983, 11:5413-5431
25. Hatada I, Tokino T, Ochiya T, Matsubara K: Coamplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Oncogene 1988, 3:537-540
26. Koda T, Matsushima S, Sasaki A, Danjo Y, Kakinuma M: c-myc gene amplification in primary stomach cancer. Jpn J Cancer Res 1985, 76:551-554
27. van de Vijver M, van de Bersselaar R, Devilee P, Cornelisse C, Peterse J, Nusse R: Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 1987, 7:2019-2023
28. Kawai J, Hirose K, Fushiki S, Hirotsune S, Ozawa N, Hara A, Hayashizaki Y, Watanabe S: Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol Cell Biol 1994, 14:7421-7427
29. Miwa W, Yashima K, Sekine T, Sekiya T: Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis 1995, 16:227-232
30. Lindsay S, Bird AP: Use of restriction enzyme to detect potential gene sequences in mammalian DNA. Nature 1987, 327:336-338
31. Sakai, T, Toguchida J, Ohtani N, Yandell DW, Rapport JM, Dryja TP: Allele-specific hypomethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991, 48:880-888
32. Morton RA, Bova GS, Isaacs WB: Hypermethylation of chromosome 17p13.3 in human adenocarcinoma of the prostate. J Urol 1993, 149:376A
33. Collins VP, Kunimi K, Bergerheim U, Ekman P: Molecular genetics and human prostate carcinoma. Acta Oncol 1991, 30:1881-1885
34. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990, 87:8751-8755
35. Rinker-Schaeffer CW, Hawkins AL, Ru N, Dong J, Stoica G, Griffin CA, Ichikawa T, Barrett JC, Isaacs JT: Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res 1994, 54:6249-6256
36. Visakorpi T, Kallioniemi AH, Syvanen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995, 55:342-347
37. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB: Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 1995, 55:4813-4817
38. Konishi N, Hiasa Y, Hayashi I, Matsuda H, Tsuzuki T, Tao M, Katahori Y, Shiraishi T, Yatani R, Shimazaki J: p53 mutations occur in clinical, but not latent, human prostate carcinoma. Jpn J Cancer Res 1995, 86:57-63
39. INK4B gene alterations with immonohistochemical studies in human prostate carcinomas. Int J Oncol 1996, 8:107-112
40. Konishi N, Hiasa Y, Tao M, Matsuda H, Nakamura M, Yane K, Kitahori Y: Focal distribution of p16/CDKN2 gene mutations within individual prostate carcinomas. Int J Oncol 1996, 8:549-554
41. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ, Epstein JI: Prostate cancer: pathological features of hereditary prostate cancer. J Urol 1995, 153:987-992
42. Emmert-Buck MR, Vocke CD, Pazzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM: Allelic loss on chromosome 8p 12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 1995, 55:2959-2962